Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Standard tacrolimus
DRUG
2 trials
Sponsors
Novartis Pharmaceuticals
, Tomoaki Kato
Conditions
Liver Transplantation
Orthotopic Liver Transplant
Phase 2
Everolimus Post Orthotopic Liver Transplant
NCT01998789
Tomoaki Kato
Orthotopic Liver Transplant
Start: 2013-10-31
End: 2019-02-28
Target: 50
Updated: 2017-08-10
Phase 3
Efficacy and Safety of Everolimus in Liver Transplant Recipients of Living Donor Liver Transplants
Completed
NCT01888432
Novartis Pharmaceuticals
Liver Transplantation
Start: 2013-09-25
End: 2018-04-21
Updated: 2019-03-18
Related Papers
Renal Function Outcomes with Everolimus Plus Reduced-Exposure Tacrolimus in de Novo Living Donor Liver Transplantation
Transplantation
2018-07-01
6 citations
Efficacy and safety of everolimus with reduced tacrolimus in living-donor liver transplant recipients: 12-month results of a randomized multicenter study.
2018-01-25
53 citations